Zhitong Finance App News, Cube Pharmaceutical (003020.SZ) issued an announcement. Recently, the company received the “Notice of Approval of the Marketing Application for Chemical Ingredient” for cloprocaine hydrochloride issued by the State Drug Administration. Cloprocaine hydrochloride is a local anesthetic that blocks sodium ion channels in nerve endings, making nerve impulses unable to be transmitted, thereby blocking the conduction of sensory nerve endings and producing local anesthetic effects. Its formulation is suitable for local infiltration anesthesia, peripheral nerve block anesthesia, sacral canal and epidural anesthesia.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.